A detailed history of New South Capital Management Inc transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, New South Capital Management Inc holds 158,596 shares of TMO stock, worth $98.1 Million. This represents 4.22% of its overall portfolio holdings.

Number of Shares
158,596
Previous 159,126 0.33%
Holding current value
$98.1 Million
Previous $92.5 Million 5.17%
% of portfolio
4.22%
Previous 4.17%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$541.52 - $599.02 $287,005 - $317,480
-530 Reduced 0.33%
158,596 $87.7 Million
Q1 2024

May 07, 2024

SELL
$528.82 - $599.43 $2.52 Million - $2.86 Million
-4,769 Reduced 2.91%
159,126 $92.5 Million
Q4 2023

Feb 06, 2024

SELL
$431.41 - $532.94 $2.13 Million - $2.63 Million
-4,933 Reduced 2.92%
163,895 $87 Million
Q3 2023

Oct 24, 2023

SELL
$498.29 - $574.41 $869,017 - $1 Million
-1,744 Reduced 1.02%
168,828 $85.5 Million
Q2 2023

Aug 22, 2023

SELL
$508.46 - $591.13 $5.67 Million - $6.6 Million
-11,159 Reduced 6.14%
170,572 $89 Million
Q1 2023

May 10, 2023

SELL
$535.0 - $604.82 $1.71 Million - $1.94 Million
-3,200 Reduced 1.73%
181,731 $105 Million
Q4 2022

Feb 10, 2023

SELL
$484.71 - $571.37 $2.14 Million - $2.53 Million
-4,424 Reduced 2.34%
184,931 $102 Million
Q3 2022

Nov 09, 2022

SELL
$507.19 - $604.49 $1.86 Million - $2.21 Million
-3,658 Reduced 1.9%
189,355 $96 Million
Q2 2022

Aug 12, 2022

SELL
$500.9 - $612.21 $1.44 Million - $1.76 Million
-2,867 Reduced 1.46%
193,013 $105 Million
Q1 2022

May 12, 2022

SELL
$524.0 - $644.92 $3.76 Million - $4.63 Million
-7,181 Reduced 3.54%
195,880 $116 Million
Q4 2021

Feb 11, 2022

SELL
$569.0 - $667.24 $4.43 Million - $5.2 Million
-7,788 Reduced 3.69%
203,061 $135 Million
Q3 2021

Nov 03, 2021

SELL
$509.53 - $609.78 $21.9 Million - $26.2 Million
-42,977 Reduced 16.93%
210,849 $120 Million
Q2 2021

Aug 11, 2021

SELL
$441.0 - $508.24 $2.39 Million - $2.75 Million
-5,412 Reduced 2.09%
253,826 $128 Million
Q1 2021

May 26, 2021

SELL
$439.85 - $518.83 $1.14 Million - $1.35 Million
-2,597 Reduced 0.99%
259,238 $118 Million
Q4 2020

Feb 09, 2021

SELL
$435.06 - $527.66 $3.45 Million - $4.18 Million
-7,925 Reduced 2.94%
261,835 $122 Million
Q3 2020

Nov 13, 2020

SELL
$359.77 - $441.52 $28.5 Million - $34.9 Million
-79,102 Reduced 22.67%
269,760 $119 Million
Q2 2020

Aug 20, 2020

SELL
$275.2 - $362.34 $11.8 Million - $15.6 Million
-42,989 Reduced 10.97%
348,862 $126 Million
Q1 2020

May 12, 2020

SELL
$255.3 - $340.05 $37.7 Million - $50.2 Million
-147,730 Reduced 27.38%
391,851 $111 Million
Q4 2019

Feb 13, 2020

SELL
$271.93 - $328.04 $2.39 Million - $2.88 Million
-8,778 Reduced 1.6%
539,581 $175 Million
Q3 2019

Nov 08, 2019

SELL
$268.46 - $305.43 $28.3 Million - $32.2 Million
-105,522 Reduced 16.14%
548,359 $160 Million
Q2 2019

Aug 13, 2019

SELL
$257.51 - $295.55 $8.44 Million - $9.69 Million
-32,770 Reduced 4.77%
653,881 $192 Million
Q1 2019

May 14, 2019

SELL
$212.17 - $273.72 $5.67 Million - $7.31 Million
-26,707 Reduced 3.74%
686,651 $188 Million
Q4 2018

Feb 12, 2019

SELL
$208.47 - $251.98 $9.59 Million - $11.6 Million
-45,984 Reduced 6.06%
713,358 $160 Million
Q3 2018

Nov 13, 2018

SELL
$205.57 - $244.32 $12.7 Million - $15.1 Million
-61,913 Reduced 7.54%
759,342 $185 Million
Q2 2018

Aug 14, 2018

SELL
$203.14 - $219.53 $5.38 Million - $5.81 Million
-26,470 Reduced 3.12%
821,255 $170 Million
Q1 2018

May 03, 2018

SELL
$192.98 - $224.11 $7.03 Million - $8.17 Million
-36,446 Reduced 4.12%
847,725 $175 Million
Q4 2017

Feb 13, 2018

BUY
$182.03 - $200.37 $2.87 Million - $3.16 Million
15,775 Added 1.82%
884,171 $168 Million
Q3 2017

Nov 13, 2017

BUY
$171.74 - $194.04 $149 Million - $169 Million
868,396
868,396 $164 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $242B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track New South Capital Management Inc Portfolio

Follow New South Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New South Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on New South Capital Management Inc with notifications on news.